ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers
January 09, 2020HMBD-001 was developed using Hummingbird Bioscience's proprietary Rational Antibody Discovery Platform to specifically bind to and inhibit a difficult-to-access region of the HER3 protein that is essential for activation. -
Voyager Therapeutics Announces Publication of Vectored Anti-Tau Monoclonal Antibody Study in The Jou
January 26, 2017Voyager Therapeutics, Inc. announced the publication of new preclinical data highlighting markedly reduced tau pathology including neurofibrillary tangles and neurodegeneration...
Pharma Sources Insight January 2025
